United Laboratories International Holdings Ltd
HKEX:3933
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
United Laboratories International Holdings Ltd
Cash from Financing Activities
United Laboratories International Holdings Ltd
Cash from Financing Activities Peer Comparison
1177
HCM
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Financing Activities
-¥1.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Cash from Financing Activities
-HK$1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Financing Activities
-¥6.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-31%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Financing Activities
-¥584.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Financing Activities
-HK$4.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Financing Activities
$48.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
See Also
What is United Laboratories International Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
-1.4B
CNY
Based on the financial report for Dec 31, 2023, United Laboratories International Holdings Ltd's Cash from Financing Activities amounts to -1.4B CNY.
What is United Laboratories International Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-12%
Over the last year, the Cash from Financing Activities growth was -5 539%. The average annual Cash from Financing Activities growth rates for United Laboratories International Holdings Ltd have been 11% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
